Anahid Ehteda
Overview
Explore the profile of Anahid Ehteda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen C, Davies J, Ashok A, Hoang T, Ehteda A, Dang T, et al.
Adv Healthc Mater
. 2025 Feb;
:e2404623.
PMID: 39962833
Recent advancements in teleoperated surgical robotic systems (TSRSs) for minimally invasive surgery (MIS) have significantly improved diagnostic and surgical outcomes. However, as the complexity of MIS procedures continues to grow,...
2.
Upton D, Liu J, George S, Valvi S, Ung C, Rayner B, et al.
Neuro Oncol
. 2025 Feb;
PMID: 39935375
Background: Diffuse midline glioma, characterised by H3K27 alteration (DMG), is the predominant high-grade glioma in children. It commonly originates in the brainstem, yet effective treatments for these patients remain elusive....
3.
Ehteda A, Khan A, Rajakumar G, Vanniasinghe A, Gopalakrishnan A, Liu J, et al.
Mol Cancer Ther
. 2023 Sep;
22(12):1413-1421.
PMID: 37683275
Diffuse intrinsic pontine gliomas (DIPG) are an incurable childhood brain cancer for which novel treatments are needed. DIPGs are characterized by a mutation in the H3 histone (H3K27M), resulting in...
4.
Xiao L, Somers K, Murray J, Pandher R, Karsa M, Ronca E, et al.
Clin Cancer Res
. 2021 May;
27(15):4338-4352.
PMID: 33994371
Purpose: We investigated whether targeting chromatin stability through a combination of the curaxin CBL0137 with the histone deacetylase (HDAC) inhibitor, panobinostat, constitutes an effective multimodal treatment for high-risk neuroblastoma. Experimental...
5.
Ehteda A, Simon S, Franshaw L, Giorgi F, Liu J, Joshi S, et al.
Cell Rep
. 2021 Apr;
35(2):108994.
PMID: 33852836
Diffuse intrinsic pontine glioma (DIPG) is an aggressive and incurable childhood brain tumor for which new treatments are needed. CBL0137 is an anti-cancer compound developed from quinacrine that targets facilitates...
6.
Ung C, Tsoli M, Liu J, Cassano D, Pocovi-Martinez S, Upton D, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33805713
Diffuse Intrinsic Pontine Gliomas (DIPGs) are highly aggressive paediatric brain tumours. Currently, irradiation is the only standard treatment, but is palliative in nature and most patients die within 12 months...
7.
Khan A, Gamble L, Upton D, Ung C, Yu D, Ehteda A, et al.
Nat Commun
. 2021 Feb;
12(1):971.
PMID: 33579942
Diffuse intrinsic pontine glioma (DIPG) is an incurable malignant childhood brain tumor, with no active systemic therapies and a 5-year survival of less than 1%. Polyamines are small organic polycations...
8.
Tsoli M, Shen H, Mayoh C, Franshaw L, Ehteda A, Upton D, et al.
J Neurooncol
. 2018 Nov;
141(2):265.
PMID: 30484110
There are two errors and one omission in the original article. Author Gottardo's correct name is Nicholas G. Gottardo, author Hulleman's correct affiliation is no. 3 (VUMC, Amsterdam), and the...
9.
Tsoli M, Shen H, Mayoh C, Franshaw L, Ehteda A, Upton D, et al.
J Neurooncol
. 2018 Nov;
141(2):253-263.
PMID: 30446898
Purpose: Diffuse intrinsic pontine glioma is the most aggressive form of high grade glioma in children with no effective therapies. There have been no improvements in survival in part due...
10.
Tsoli M, Liu J, Franshaw L, Shen H, Cheng C, Jung M, et al.
Oncotarget
. 2018 Feb;
9(7):7541-7556.
PMID: 29484131
Diffuse Intrinsic Pontine Gliomas (DIPG) are the most devastating of all pediatric brain tumors. They mostly affect young children and, as there are no effective treatments, almost all patients with...